Sanofi provided earnings guidance for the year 2021. For the period, the company now expects EPS to grow around 12% at CER, barring unforeseen major adverse events. Applying average July 2021 exchange rates, the currency impact on 2021 business EPS is estimated to be between -4% to -5%.